Cancer incidence in Nigeria: A report from population-based cancer registries

Cancer Epidemiology

Volumn 36, Issue 5, 2012, Pages 271-278

  Jedy Agba, Elima ^a   Curado, Maria Paula ^b   Ogunbiyi, Olufemi ^c   Oga, Emmanuel ^a   Fabowale, Toyin ^c   Igbinoba, Festus ^d   Osubor, Gloria ^d   Otu, Theresa ^e   Kumai, Henry ^e   Koechlin, Alice ^b   Osinubi, Patience ^f   Dakum, Patrick ^a   Blattner, William ^g,h   Adebamowo, Clement A ^a,g,h  

^a INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^b INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d NATIONAL HOSPITAL   (Nigeria)

^e UNIVERSITY OF ABUJA   (Nigeria)

^f Federal Secretariat   (Nigeria)

^g UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^h UNIVERSITY OF MARYLAND   (United States)

Author keywords

Cancer incidence; Cancer registration; Population based cancer registries (PBCR); Sub Saharan Africa (SSA)

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; COLORECTAL CANCER; ETHNICITY; FEMALE; HUMAN; KAPOSI SARCOMA; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; NIGERIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; SEX DIFFERENCE; SKIN CANCER; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; NIGERIA; PROSTATIC NEOPLASMS; REGISTRIES; SEX DISTRIBUTION; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84865861540     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.04.007     Document Type: Article

References (26)

1. Sylla B.S., Wild C.P. A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent?. Int J Cancer 2011.
2. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
3. Boyle P., Levin B. World cancer report 2008 2008, International Agency for Research on Cancer, Lyon, France.
4. Lyerly H.K., Abernethy A.P., Stockler M.R., Koczwara B., Aziz Z., Nair R., et al. Need for global partnership in cancer care: perceptions of cancer care researchers attending the 2010 Australia and Asia Pacific clinical oncology research development workshop. J Oncol Pract 2011, 7:324-329.
5. Cancer incidence in five continents 2008, vol. IX. IARC Scientific Publication No. 160, http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9-A.pdf [accessed 18.10.11].
6. Parkin D.M., Wabinga H., Nambooze S., Wabwire-Mangen F. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS 1999, 13:2563-2570.
7. Wabinga H., Parkin D.M., Nambooze S., Amero J. Cancer survival in Kampala, Uganda, 1993-1997 2011, IARC Scientific Publication, p. 243-7.
8. Chokunonga E., Levy L.M., Bassett M.T., Borok M.Z., Mauchaza B.G., Chirenje M.Z., et al. Aids and cancer in Africa: the evolving epidemic in Zimbabwe. AIDS 1999, 13:2583-2588.
9. Ckokunonga E., Borok M.Z., Chirenje Z.M., Nyabakau A.M., Parkin D.M. Cancer survival in Zimbabwe 1993-1997 2011, 162. IARC Scientific Publication, p. 249-55.
10. Bah E., Sam O., Whittle H., Ramanakumar A., Sankaranarayanan R. Cancer survival in the Gambia, 1993-1997 2011, IARC Scientific Publication, p. 97-100.
11. Cancer in Africa 2003, IARC Scientific Publication No. 153, http://www.iarc.fr/en/publications/pdfs-online/epi/index.php [accessed 25.10.11].
12. Parkin D.M., Ferlay J., Curado M.P., Bray F., Edwards B., Shin H.R., et al. Fifty years of cancer incidence: CI5 I-IX. Int J Cancer 2010, 127:2918-2927.
13. International classification of diseases for oncology 2000, World Health Organisation. 3rd ed.
14. Smith J.A. The impact of skin disease on the quality of life of adolescents. Adolesc Med 2001, 12. vii, 343-53.
15. Forouzanfar M.H., Foreman K.J., Delossantos A.M., Lozano R., Lopez A.D., Murray C.J., et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011.
16. Mills E.J., Bakanda C., Birungi J., Chan K., Hogg R.S., Ford N., et al. Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda. J Int AIDS Soc 2011, 14:52.
17. Bray F., Parkin D.M. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 2009, 45:747-755.
18. Curado M.P., Voti L., Sortino-Rachou A.M. Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care. Cancer Causes Control 2009, 20:751-756.
19. Arowolo O.A., Akinkuolie A.A., Lawal O.O., Alatise O.I., Salako A.A., Adisa A.O. The impact of neoadjuvant chemotherapy on patients with locally advanced breast cancer in a Nigerian semiurban teaching hospital: a single-center descriptive study. World J Surg 2010, 34:1771-1778.
20. Anyanwu S.N. Breast cancer in eastern Nigeria: a ten year review. West Afr J Med 2000, 19:120-125.
21. Sitas F., Pacella-Norman R., Carrara H., Patel M., Ruff P., Sur R., et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 2000, 88:489-492.
22. Piras F., Piga M., De Montis A., Zannou A.R., Minerba L., Perra M.T., et al. Prevalence of human papillomavirus infection in women in Benin, West Africa. Virol J 2011, 8:514.
23. Chornokur G., Dalton K., Borysova M.E., Kumar N.B. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate 2011, 71:985-997.
24. Bah E., Parkin D.M., Hall A.J., Jack A.D., Whittle H. Cancer in the Gambia: 1988-97. Br J Cancer 2001, 84:1207-1214.
25. Akinwande O., Ogundiran T., Akarolo-Anthony S., Mamadu I., Dakum P., Blattner W., et al. Challenges in treating malignancies in HIV in Nigeria. Curr Opin Oncol 2009, 21:455-461.
26. Martin-Carbonero L., Palacios R., Valencia E., Saballs P., Sirera G., Santos I., et al. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin. Clin Infect Dis 2008, 47:410-417.